LIPELLA PHARMACEUTICALS INC. (LIPO) Cash flow
Market cap
$924.17
P/E ratio
| 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | - | 1,685 | 2,886 |
| Cash from operations | -1,831,161 | -3,150,172 | -3,950,747 |
| Capital expenditures | - | -14,434 | - |
| Cash from investing | 300,546 | -14,434 | - |
| Cash from financing | 5 | 1 | 3 |
| Free cash flow | - | - | |
| FCF margin (%) | - | - |